The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme

Publisher： Karger

E-ISSN： 1423-0232|84|6|326-335

ISSN： 0030-2414

Source： Oncology, Vol.84, Iss.6, 2013-04, pp. : 326-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of temozolomide as a radiosensitiser for the treatment of newly diagnosed glioblastoma multiforme

By  

Journal of Radiotherapy in Practice, Vol. 6, Iss. 2, 2007-06 ,pp. : 103-110

Cambridge University Press

Access to resources Recommend Favorite

Congenital Glioblastoma Multiforme: Complete Resection with Long-Term Survival and a Novel Technique of Contralateral Cystoventriculostomy

By  

Pediatric Neurosurgery, Vol. 48, Iss. 5, 2013-07 ,pp. : 327-330

Karger

Access to resources Recommend Favorite

Cerebral gumma mimicking glioblastoma multiforme

By Ances Beau   Danish Shabbar   Kolson Dennis   Judy Kevin   Liebeskind David  

Neurocritical Care, Vol. 2, Iss. 3, 2004-03 ,pp. : 300-302

Humana Press, Inc

Access to resources Recommend Favorite

Multicentric Cerebellopontine Angle Glioblastoma Multiforme

By  

Pediatric Neurosurgery, Vol. 44, Iss. 3, 2008-03 ,pp. : 224-228

Karger

Access to resources Recommend Favorite

Biomarkers and therapeutic advances in glioblastoma multiforme

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 14, Iss. 1, 2018-02 ,pp. : 40-51

John Wiley & Sons Inc

Access to resources Recommend Favorite